论文部分内容阅读
原发性支气管肺癌的血液供给来自支气管动脉。选择性支气管动脉造影并局部灌注化疗药物是抗癌药物进入肿瘤体的最好途径。本文总结30例(河南医科大学附二院及新乡医学院附二院各15例),晚期支气管肺癌病人经支气管动脉灌注化疗药物进行治疗,现报告如下:一般资料一、资料:本组所有病例经胸片、纤维支气管镜检查,病理证实为原发性支气管肺癌。30例中,右上7例,右中4例,右下7例,左下3例,左上8例,左主支气管1例。其中男25例,女5例,最大年龄65岁,最小年龄42岁。鳞状上皮细胞癌13例,腺癌
The blood supply of primary bronchogenic lung cancer comes from the bronchial artery. Selective bronchial arteriography and local infusion of chemotherapeutic drugs are the best ways for anticancer drugs to enter the tumor body. This article summarizes 30 cases (15 cases each of the Second Affiliated Hospital of Henan Medical University and the Second Affiliated Hospital of Xinxiang Medical College). Patients with advanced bronchial lung cancer were treated with bronchial arterial infusion chemotherapy drugs. The present report is as follows: General Information I. Information: All cases in this group Transthoracic and fiberoptic bronchoscopy confirmed primary pathological lung cancer. Among the 30 cases, there were 7 cases in the upper right, 4 cases in the right, 7 cases in the lower right, 3 cases in the lower left, 8 cases in the upper left, and 1 case in the left main bronchus. There were 25 males and 5 females, with the maximum age of 65 years and the minimum age of 42 years. Squamous cell carcinoma in 13 cases, adenocarcinoma